1DD-LSD: Difference between revisions
Appearance
Content deleted Content added
←Created page with '{{Drugbox | IUPAC_name = (6a''R'',9''R'')-''N'',''N''-diethyl-6-methyl-4-dodecanoyl-4,6,6a,7,8,9-hexahydroindolo[4,3-''fg'']quinoline-9-carboxamide | image = 1DD-LSD_structure.png | width = 220 <!--Clinical data--> | tradename = | legal_AU = | legal_BR = | legal_CA = | legal_DE = | legal_UK = | legal_US = | legal_US_comment = | legal_status = | routes_of_administration = <!--Identifiers--> | CAS_number = | PubChem = | ChemSpiderID = | UNII...' |
No edit summary |
||
Line 23: | Line 23: | ||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C= | H= |
| C=32 | H=47 | N=3 | O=2 |
||
| smiles = |
| smiles = |
||
| StdInChI = |
| StdInChI = |
Revision as of 07:53, 7 May 2024
Identifiers | |
---|---|
| |
Chemical and physical data | |
Formula | C32H47N3O2 |
Molar mass | 505.747 g·mol−1 |
1DD-LSD (N1-dodecanoyl-lysergic acid diethylamide) is an acylated derivative of lysergic acid diethylamide (LSD). In animal studies it produces a weak head-twitch response but with 27x lower potency than LSD itself. It is being researched as a potential slow-onset, long lasting prodrug for LSD which is expected to have reduced psychoactive effects.[1]
See also
References
- ^ Kavanagh PV, Westphal F, Pulver B, Elliott SP, Stratford A, Halberstadt AL, Brandt SD. Analytical and behavioral characterization of 1-dodecanoyl-LSD (1DD-LSD). Drug Test Anal. 2024 Apr 3. doi:10.1002/dta.3691 PMID 38569566